Biotech · Private company
Biohaven Pharmaceuticals, Inc.
Track this companyFree. Adds Biohaven Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials194 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- taldefgrobep alfaPhase 3 · Spinal Muscular AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- troriluzolePhase 3 · Spinocerebellar AtaxiasClinicalTrials.gov · fetched Nov 12, 2026
- TroriluzolePhase 3 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- TroriluzolePhase 3 · Obsessive-Compulsive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Troriluzole (BHV-4157)Phase 3 · Obsessive Compulsive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- VerdiperstatPhase 3 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- troriluzolePhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BHV-0223Phase 1 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- BHV-1100 plus cytokine induced memory-like (CIML) NK cells plus IVIG and low dose IL-2Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- BHV3241, verdiperstatMultiple System Atrophy (MSA)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- BHV-7000 Responsive Neurostimulation System (RNS) StudyPHASE1 · COMPLETED · started Oct 7, 2025ClinicalTrials.gov NCT07125261 · fetched Nov 12, 2026
- A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type GlioblastomaEARLY_PHASE1 · RECRUITING · started Feb 19, 2025ClinicalTrials.gov NCT06552260 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular AtrophyPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 6, 2022ClinicalTrials.gov NCT05337553 · fetched Nov 12, 2026
- Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma PatientsPHASE1 · COMPLETED · started Oct 21, 2021ClinicalTrials.gov NCT04634435 · fetched Nov 12, 2026
- Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain MetsPHASE2 · TERMINATED · started Jun 30, 2021ClinicalTrials.gov NCT04899921 · fetched Nov 12, 2026
- Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive DisorderPHASE3 · TERMINATED · started Mar 30, 2021ClinicalTrials.gov NCT04708834 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive DisorderPHASE3 · COMPLETED · started Jan 29, 2021ClinicalTrials.gov NCT04693351 · fetched Nov 12, 2026
- Effect of Verdiperstat on Microglial Activation in Well-characterized MSA PatientsEARLY_PHASE1 · COMPLETED · started Dec 30, 2020ClinicalTrials.gov NCT04616456 · fetched Nov 12, 2026
- Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive DisorderPHASE3 · COMPLETED · started Dec 22, 2020ClinicalTrials.gov NCT04641143 · fetched Nov 12, 2026
- HEALEY ALS Platform Trial - Regimen B VerdiperstatPHASE2_PHASE3 · COMPLETED · started Jul 28, 2020ClinicalTrials.gov NCT04436510 · fetched Nov 12, 2026
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2_PHASE3 · RECRUITING · started Jul 30, 2019ClinicalTrials.gov NCT03970447 · fetched Nov 12, 2026
- Study of BHV-3241 in Participants With Multiple System AtrophyPHASE3 · COMPLETED · started Jul 29, 2019ClinicalTrials.gov NCT03952806 · fetched Nov 12, 2026
- Troriluzole in Adult Participants With Spinocerebellar AtaxiaPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 8, 2019ClinicalTrials.gov NCT03701399 · fetched Nov 12, 2026
- Randomized Trial of Adult Participants With Generalized Anxiety DisorderPHASE3 · COMPLETED · started Feb 19, 2019ClinicalTrials.gov NCT03829241 · fetched Nov 12, 2026
- Study of BHV-4157 in Alzheimer's DiseasePHASE2 · COMPLETED · started Jul 31, 2018ClinicalTrials.gov NCT03605667 · fetched Nov 12, 2026
- Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALSPHASE1 · COMPLETED · started Feb 2, 2018ClinicalTrials.gov NCT03520517 · fetched Nov 12, 2026
- Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive DisorderPHASE2_PHASE3 · COMPLETED · started Dec 19, 2017ClinicalTrials.gov NCT03299166 · fetched Nov 12, 2026
- Trial in Adult Participants With Spinocerebellar Ataxia (SCA)PHASE2_PHASE3 · COMPLETED · started Dec 15, 2016ClinicalTrials.gov NCT02960893 · fetched Nov 12, 2026
- Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)NO_LONGER_AVAILABLEClinicalTrials.gov NCT05086094 · fetched Nov 12, 2026